Skip to main content
Market intelligence
PRLDHealthcare

Prelude Therapeutics Inc insider activity

In the last 90 days, 5 corporate insiders purchased $62,499,993 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$62,499,993
Corporate buyers
5
Latest transaction
Apr 21, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Apr 21, 2026David P BonitaCorporate insiderOpen Market Purchase2,815,315$4.44$12,499,999
Apr 21, 2026Orbimed Advisors LlcCorporate insiderOpen Market Purchase2,815,315$4.44$12,499,999
Apr 21, 2026Orbimed Capital LlcCorporate insiderOpen Market Purchase2,815,315$4.44$12,499,999